Insider NameBuy/SellCompany NameTickerAmountShares Change
Dec 06, 2022Dec 08, 2022Staab Thomas R II
CFO
BuyLensar, Inc.LNSR$3.16$8,697+2.00%
May 16, 2019May 20, 2019Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$7.65$74,595-7.23%
May 14, 2019May 16, 2019Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$7.81$91,710-8.28%
May 09, 2019May 13, 2019Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$7.7$150,053-12.81%
May 02, 2019May 06, 2019Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$7.54$126,325-11.21%
Apr 04, 2019Apr 08, 2019Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$8.81$66,075-5.35%
Jan 28, 2019Jan 30, 2019Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$9.85$49,250-3.75%
Dec 04, 2018Dec 06, 2018Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$9.45$37,063-2.85%
Nov 19, 2018Nov 21, 2018Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$8.67$97,117-7.54%
Nov 07, 2018Nov 09, 2018Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$8.12$114,387-9.30%
Nov 05, 2018Nov 07, 2018Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$8$1,720-0.16%
Nov 02, 2018Nov 06, 2018Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$7.84$85,090-7.32%
Oct 19, 2018Oct 23, 2018Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$7.45$23,468-2.24%
Oct 02, 2018Oct 04, 2018Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$7.24$71,358-6.69%
Mar 20, 2017Mar 22, 2017Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$9.2$29,900-2.25%
Mar 10, 2017Mar 14, 2017Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$9.06$29,445-2.70%
Mar 08, 2017Mar 10, 2017Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$8.43$54,763-5.25%
Mar 06, 2017Mar 08, 2017Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$7.9$25,675-2.70%
Dec 19, 2016Dec 21, 2016Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$7.45$24,213-2.55%
Aug 11, 2016Aug 15, 2016Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$5.18$30,388-4.51%
Aug 09, 2016Aug 11, 2016Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$4.43$64,576-10.08%
Dec 21, 2015Dec 22, 2015Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$10.86$33,145-2.19%
Dec 17, 2015Dec 18, 2015Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$10.49$31,470-2.10%
Jul 20, 2015Jul 22, 2015Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$16.5$57,750-2.39%
Jun 22, 2015Jun 24, 2015Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$16$60,000-2.50%
Jun 18, 2015Jun 22, 2015Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$14.36$235,150-10.08%
Jun 05, 2015Jun 09, 2015Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$12.75$76,500-3.77%
Jun 01, 2015Jun 02, 2015Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$12$36,000-1.85%
May 18, 2015May 19, 2015Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$11$33,000-1.82%
Dec 29, 2014Dec 31, 2014Staab Thomas R II
SVP
CFO
SellBiocryst Pharmaceuticals IncBCRX$12.56$119,320-5.51%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.